Sijie J. Wang

Internal Medicine

250 Pleasant St
Concord, NH 03301

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Covalent Protein Inhibitors via Tyrosine and Tryptophan Conjugation with Cyclic Imine Mannich Electrophiles.

Covalent Protein Inhibitors via Tyrosine and Tryptophan Conjugation with Cyclic Imine Mannich Electrophiles.

Journal: Angewandte Chemie (International ed. in English)

Published: July 29, 2025

Track-A-Worm 2.0: A Software Suite for Quantifying Properties of C. elegans Locomotion, Bending, Sleep, and Action Potentials.

Track-A-Worm 2.0: A Software Suite for Quantifying Properties of C. elegans Locomotion, Bending, Sleep, and Action Potentials.

Journal: eNeuro

Published: June 11, 2025

Track-A-Worm 2.0: A Software Suite for Quantifying Properties of C. elegans Locomotion, Bending, Sleep, and Action Potentials.

Track-A-Worm 2.0: A Software Suite for Quantifying Properties of C. elegans Locomotion, Bending, Sleep, and Action Potentials.

Journal: bioRxiv : the preprint server for biology

Published: September 24, 2024

Rational Design and Development of Selective BRD7 Bromodomain Inhibitors and Their Activity in Prostate Cancer.

Rational Design and Development of Selective BRD7 Bromodomain Inhibitors and Their Activity in Prostate Cancer.

Journal: Journal of medicinal chemistry

Published: August 08, 2023

Corrigendum to 'Effect of Inpatient Medication-Assisted Therapy on Against-Medical-Advice Discharge and Readmission Rates' The American Journal of Medicine (2020) 1343-1349.

Corrigendum to 'Effect of Inpatient Medication-Assisted Therapy on Against-Medical-Advice Discharge and Readmission Rates' The American Journal of Medicine (2020) 1343-1349.

Journal: The American journal of medicine

Published: March 20, 2022

Polycomb Paralog Chromodomain Inhibitors Active against Both CBX6 and CBX8*.

Polycomb Paralog Chromodomain Inhibitors Active against Both CBX6 and CBX8*.

Journal: ChemMedChem

Published: April 12, 2021

Polycomb group proteins in cancer: multifaceted functions and strategies for modulation.

Polycomb group proteins in cancer: multifaceted functions and strategies for modulation.

Journal: NAR cancer

Published: April 09, 2021

A Potent, Selective CBX2 Chromodomain Ligand and Its Cellular Activity During Prostate Cancer Neuroendocrine Differentiation.

A Potent, Selective CBX2 Chromodomain Ligand and Its Cellular Activity During Prostate Cancer Neuroendocrine Differentiation.

Journal: Chembiochem : a European journal of chemical biology

Published: March 12, 2021

Effect of Inpatient Medication-Assisted Therapy on Against-Medical-Advice Discharge and Readmission Rates.

Effect of Inpatient Medication-Assisted Therapy on Against-Medical-Advice Discharge and Readmission Rates.

Journal: The American journal of medicine

Published: February 15, 2020

Optimization of Ligands Using Focused DNA-Encoded Libraries To Develop a Selective, Cell-Permeable CBX8 Chromodomain Inhibitor.

Optimization of Ligands Using Focused DNA-Encoded Libraries To Develop a Selective, Cell-Permeable CBX8 Chromodomain Inhibitor.

Journal: ACS chemical biology

Published: November 23, 2019

An Unusual Cause of Stroke: Neurosarcoidosis.

An Unusual Cause of Stroke: Neurosarcoidosis.

Journal: The American journal of medicine

Published: July 23, 2019

Robustness of In Vitro Selection Assays of DNA-Encoded Peptidomimetic Ligands to CBX7 and CBX8.

Robustness of In Vitro Selection Assays of DNA-Encoded Peptidomimetic Ligands to CBX7 and CBX8.

Journal: SLAS discovery : advancing life sciences R & D

Published: January 09, 2018

Showing 1-12 of 16

Last Updated: 09/26/2026